The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer Who Received Prior Androgen Deprivation Therapy and Reached Low Prostate-Specific Antigen Levels Treated Further With Enzalutamide: Post Hoc Analyses of ARCHES
Patient-Reported Quality of Life in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole: Results From PALOMA-4
September 11, 2022 ESMO 2022 Prostate Cancer